Speeding Discovery into development
At Averica, we understand drug development is challenging. For the last 15 years, we have been supporting the pharmaceutical industry and helping to advance programs all the way from early discovery to commercial testing.
We are an expert CRO that specializes in small molecule chromatography, in particular method development, separations, and impurity isolation and identification.
PURIFICATION AND CHIRAL SEPARATION
Chiral preparative chromatography can support purification of a variety of difficult to purify substances (natural products, impurities and degradants, external contaminants). Read more…
PHARMACEUTICAL IMPURITIES
Increasing attention on impurities in product development (degradants, solvents, external contaminants, genotoxic impurities, organic or inorganic) places an unprecedented burden on sponsors. Read more..
METHOD DEVELOPMENT
Developing analytical methods that are robust, transferable, reproducible, and designed to generate quality results is the ultimate goal. Averica’s method development services ensure that your team makes the best decisions and hits drug development milestones.
Read more…
GMP SERVICES
Developing analytical methods that are robust, transferable, reproducible, and designed to generate quality results is the ultimate goal. Averica’s method development services ensure that your team makes the best decisions and hits drug development milestones.
Read more…
PHYSICAL PROPERTIES
Obtain detailed quantitative results from physical properties assessment using a range of chromatography technologies. More information coming soon.
Beautiful chromatograms. I am continually impressed with the quality of your work.
Scott Collibee
Director, Medicinal Chemistry
You have a terrific business and have become my preferred provider of analytical development services. I will have lots more studies for you in the future.
Scott Hecker
Vice President, Chemistry
We were really impressed with the speed and quality of your work! We will definitely go back to you with future chiral separation needs.
Junko Tamiya, Ph.D.